METTL3, a key executor of m6A methylation modification, has been verified to be involved in the proliferation, invasion, and metastasis of HCC cells, as well as in the glycolysis and lipogenesis processes, promoting the progression of HCC [13]. This evidence concerns the gene METTL3 and hepatocellular carcinoma.